2-(4-dimethylaminomethyl-1,2,3-triazol-1-yl)-N6-methyl-9-(beta-D-ribofuranosyl)adenine

ID: ALA374645

PubChem CID: 16094548

Max Phase: Preclinical

Molecular Formula: C16H23N9O4

Molecular Weight: 405.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1nc(-n2cc(CN(C)C)nn2)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C16H23N9O4/c1-17-13-10-14(20-16(19-13)25-5-8(21-22-25)4-23(2)3)24(7-18-10)15-12(28)11(27)9(6-26)29-15/h5,7,9,11-12,15,26-28H,4,6H2,1-3H3,(H,17,19,20)/t9-,11-,12-,15-/m1/s1

Standard InChI Key:  CRKZMZSQJYBAJR-SDBHATRESA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    5.1762   -3.6016    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8958   -3.1938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8993   -2.3633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1871   -1.9486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4646   -3.1833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4722   -2.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6862   -2.0910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1928   -2.7571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6740   -3.4321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1916   -1.1237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6078   -3.6106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6850   -4.4296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4909   -4.6061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9078   -3.8941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3594   -3.2777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9083   -0.7151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4118   -4.2144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6235   -4.4600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6160   -5.2849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3983   -5.5471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8892   -4.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6461   -6.3340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7141   -4.8915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9441   -5.7637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1935   -5.4213    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8219   -5.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3329   -6.0262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6638   -6.7820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5130   -5.9350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
  3  4  2  0
 10 16  1  0
  6  7  1  0
 17  9  1  1
 17 18  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4  6  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
  4 10  1  0
 20 22  1  6
  5  6  2  0
 21 23  1  6
  2 11  1  0
 19 24  1  1
 11 12  1  0
 24 25  1  0
  1  2  2  0
 13 26  1  0
  5  1  1  0
 26 27  1  0
  2  3  1  0
 27 28  1  0
 27 29  1  0
M  END

Associated Targets(Human)

ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 405.42Molecular Weight (Monoisotopic): 405.1873AlogP: -1.88#Rotatable Bonds: 6
Polar Surface Area: 159.50Molecular Species: NEUTRALHBA: 13HBD: 4
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.45CX Basic pKa: 6.44CX LogP: -1.38CX LogD: -1.43
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.36Np Likeness Score: -0.25

References

1. Cosyn L, Palaniappan KK, Kim SK, Duong HT, Gao ZG, Jacobson KA, Van Calenbergh S..  (2006)  2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.,  49  (25): [PMID:17149867] [10.1021/jm0608208]

Source